Source: ERS Course 2021 - COVID-19: State of the art



Rating:

Share or cite this content

Citations should be made in the following way:
W. Randerath (Solingen, Germany). COVID-19: Impact in adult patients with premorbid disease: Metabolic diseases (diabetes, obesity). ERS Course 2021 - COVID-19: State of the art

Member's Comments

No comment yet.

Related content which might interest you: Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Prevalence and diagnosis of obesity hypoventilation syndrome (OHS) in ambulatory obese patients Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea Year: 2016 Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Source: Eur Respir J 2008; 32: 962-969 Year: 2008 The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011 Cardiovascular diseases (CVD), arterial hypertension (AH) and diabetes mellitus (DM) in a cohort of 609 COPD patients: Associations with the new GOLD classification 2011 Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 Metabolic syndrome and diabetes mellitus in COPD Source: Eur Respir Mon 2013; 59: 117-134 Year: 2013 Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Prevalence of chronic kidney disease (CKD) in the UK COPD population Source: International Congress 2014 – COPD exacerbations Year: 2014 Metabolic syndrome in COPD patients without cardiovascular comorbidities: Co-existence or a different COPD phenotype? Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Prevalence of metabolic syndrome (MS) in a population of apneic patients:A prospective study with cardiovascular risk estimation Source: International Congress 2014 – Sleep disordered breathing 4 Year: 2014 Prevalence of arterial hypertension in obstructive sleep apnoea (OSA) patients – Impact of diabetes and obesity Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 Comorbidity and some issues of cardiovascular disorders in disabled asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Prevalence of COPD in vascular diseases Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Prevalence and factors associated with diabetes mellitus among tuberculosis patients: a nationwide cohort Source: Eur Respir J 2016; 48: 264-268 Year: 2016 To improvement of diagnostics of the diabetes mellitus 2 type at patients with chronic obstructive pathology of lungs Source: International Congress 2014 – COPD: points to ponder Year: 2014 The evaluation of systemic inflammation in COPD patients comorbided with cardiovascular diseases or diabetes mellitus Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Comorbidity: a distinctive feature of elderly respiratory patients Source: Eur Respir Mon; 2009: 43: 205–216 Year: 2009 Multi-symptom asthma (MSA) and comorbidities in a cohort of Italian young asthmatic subjects Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013